NCT02046941View on ClinicalTrials.gov

Brain Biomarkers of Response to Treatment for Apraxia of Speech

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 1, 2014

Primary Completion Date

January 8, 2018

Study Completion Date

June 30, 2018

Conditions
AphasiaStroke
Interventions
BEHAVIORAL

Speech Production Treatment

This treatment employs a response-contingent hierarchy made up of verbal modeling/repetition, graphic cueing, integral stimulation, and articulatory placement instruction.

Trial Locations (1)

95655

VA Northern California Health Care System, Mather, CA, Sacramento

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT02046941 - Brain Biomarkers of Response to Treatment for Apraxia of Speech | Biotech Hunter | Biotech Hunter